Zhou S - Search Results

1

Surrogate endpoints shortening the therapeutic evaluation duration for different subgroups of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A retrospective analysis of 830 patients stratified by the 8th edition of the UICC/AJCC staging system and plasma Epstein-Barr viral.

Zhou S, Chen C, Liu SR, Tao YL, Chang H, Wang XH, Yang X, Zhang WW, Liu S, Ding SR, Wang GN, Xia YF. Zhou S, et al. J Cancer. 2018 Sep 8;9(18):3352-3360. doi: 10.7150/jca.25530. eCollection 2018. J Cancer. 2018. PMID: 30271496 Free PMC article.

2

An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.

Li XH, Chang H, Xu BQ, Tao YL, Gao J, Chen C, Qu C, Zhou S, Liu SR, Wang XH, Zhang WW, Yang X, Zhou SL, Xia YF. Li XH, et al. Among authors: zhou sl, zhou s. Cancer Med. 2017 Jan;6(1):310-319. doi: 10.1002/cam4.947. Epub 2016 Nov 10. Cancer Med. 2017. PMID: 27860387 Free PMC article.

3

Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.

Chang H, Yi W, Wang X, Tao Y, Yang X, Chen C, Zhang W, Zhou S, Liu S, Li X, Ding S, Li J, Li G, Shao X, Liu Y, Song W, Xia Y. Chang H, et al. Among authors: zhou s. Chin J Cancer Res. 2018 Jun;30(3):307-314. doi: 10.21147/j.issn.1000-9604.2018.03.03. Chin J Cancer Res. 2018. PMID: 30046225 Free PMC article.

4

O Blood Type Is Associated with Unfavorable Distant-metastasis-free Survival in Female Patients with Nasopharyngeal Carcinoma: A Retrospective Study of 2439 Patients from Epidemic Area.

Wang GN, Zhou S, Chen C, Chang H, Tao Y, Liu S, Wang XH, Zhang WW, Liu Y, Liu SR, Ding SR, Yang X, Ye ZQ, Gao YF, Xia YF. Wang GN, et al. Among authors: zhou s. J Cancer. 2019 Jan 30;10(5):1297-1306. doi: 10.7150/jca.28372. eCollection 2019. J Cancer. 2019. PMID: 30854139 Free PMC article.

5

Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zheng SH, Zhou S, Wang GN, Huang ZL, Liu SR, Chen C, Tao YL, Chang H, Ding SR, Liao RN, Chen C, Xia YF. Zheng SH, et al. Among authors: zhou s. Transl Cancer Res. 2021 Nov;10(11):4624-4635. doi: 10.21037/tcr-21-1340. Transl Cancer Res. 2021. PMID: 35116319 Free PMC article.

6

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.

Qu C, Zhao Y, Feng G, Chen C, Tao Y, Zhou S, Liu S, Chang H, Zeng M, Xia Y. Qu C, et al. Among authors: zhou s. J Cell Mol Med. 2017 Nov;21(11):2872-2883. doi: 10.1111/jcmm.13200. Epub 2017 May 30. J Cell Mol Med. 2017. PMID: 28557284 Free PMC article.

7

Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports.

Chen C, Liu SR, Zhou S, Li XH, Wang XH, Tao YL, Chang H, Zhang WW, Li WF, Zhou SL, Xia YF. Chen C, et al. Among authors: zhou sl, zhou s. Medicine (Baltimore). 2019 Aug;98(32):e16592. doi: 10.1097/MD.0000000000016592. Medicine (Baltimore). 2019. PMID: 31393358 Free PMC article.

8

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis.

Zhao JJ, Zhou S, Chen CL, Zhang HX, Zhou ZQ, Wu ZR, Liu Y, Pan QZ, Zhu Q, Tang Y, Xia JC, Weng DS. Zhao JJ, et al. Among authors: zhou zq, zhou s. J Cancer. 2018 Oct 20;9(22):4204-4214. doi: 10.7150/jca.25790. eCollection 2018. J Cancer. 2018. PMID: 30519321 Free PMC article.

9

Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.

Wang L, Wu Z, Xie D, Zeng R, Cheng W, Hu J, Huang S, Zhou S, Zhong R, Su Y. Wang L, et al. Among authors: zhou s. Cancer Res Treat. 2019 Apr;51(2):685-695. doi: 10.4143/crt.2018.250. Epub 2018 Aug 13. Cancer Res Treat. 2019. PMID: 30121968 Free PMC article.

10

Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma.

Peng YL, Chen L, Shen GZ, Li YN, Yao JJ, Xiao WW, Yang L, Zhou S, Li JX, Cheng WQ, Guan Y, Xia HQ, Liu S, Zhao C, Deng XW. Peng YL, et al. Among authors: zhou s. Oral Oncol. 2018 Jul;82:1-7. doi: 10.1016/j.oraloncology.2018.04.025. Epub 2018 May 3. Oral Oncol. 2018. PMID: 29909882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,605 results

Search Page

Filters